|
The Immunohistochemistry Antibody Company
|
- Home
-
Products
- All Antibodies
- IHC-plus Antibodies
-
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
- Distributors
-
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
-
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us
|
|
Testicular Cancer Screen 2 Tissue Microarray - LS-STSCA2
This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.
|
|
| Catalog ID: |
LS-STSCA2 |
| Product Name: |
Testicular Cancer Screen 2 |
| Description: |
16 testis tumor (predominantly seminoma) and 8 normal/non-neoplastic testis specimens (duplicate cores) |
| Format: |
FFPE |
| Category: |
Human Tumor and Normal |
| QA/QC: |
H&E reviewed; IHC validated with a positive control antibody |
| Storage: |
Short term RT; Long term 4ºC |
| Clinical History: |
No |
| Tissue Marker: |
No |
| Stage/Grade: |
No |
| Core Diameter: |
2 mm |
| Core Thickness: |
4 µm |
| Cases: |
24 |
| Cores: |
48 |
| Slides Per Set: |
1 |
LS-STSCA2 Tissue Microarray Map
Slide Number 1
| LABEL | | | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | | A | Tes | Pen | Tes | Tes | Tes | Tes | Pen | Tes | | B | Tes | Pen | Tes | Tes | Tes | Tes | Pen | Tes | | C | Tes | Tes | Tes | Tes | Tes | Tes | Tes | Tes | | D | Tes | Tes | Tes | Tes | Tes | Tes | Tes | Tes | | E | Tes | Tes | Tes | Tes | Tes | Tes | Tes | Tes | | F | Tes | Tes | Tes | Tes | Tes | Tes | Tes | Tes |
|
Diagnosis Type Legend| Benign non-neoplastic | Diseased | Inflammatory | Malignant | Metastatic | Tumor | Unknown |
Element Tissue LegendPenis, Epididymis (Pen); Testis (Tes);
LS-STSCA2 Element Details
| Slide | Position | Species | Gender | Age | Tissue | Diagnosis | Diagnosis Type |
|---|
| 1 | A1 | Human | M | 73 y | Testis (Tes) | Normal | Benign non-neoplastic |
| 1 | A2 | Human | M | 36 y | Penis, Epididymis (Pen) | Granuloma | Inflammatory |
| 1 | A3 | Human | M | 51 y | Testis (Tes) | Fibrohistiocytosis | Tumor |
| 1 | A4 | Human | M | 70 y | Testis (Tes) | Normal | Benign non-neoplastic |
| 1 | A5 | Human | M | 47 y | Testis (Tes) | Tuberculosis | Diseased |
| 1 | A6 | Human | M | 30 y | Testis (Tes) | Tuberculosis | Diseased |
| 1 | A7 | Human | M | 58 y | Penis, Epididymis (Pen) | Adenoma | Tumor |
| 1 | A8 | Human | M | 63 y | Testis (Tes) | Seminoma | Tumor |
| 1 | B1 | Human | M | 73 y | Testis (Tes) | Normal | Benign non-neoplastic |
| 1 | B2 | Human | M | 36 y | Penis, Epididymis (Pen) | Granuloma | Inflammatory |
| 1 | B3 | Human | M | 51 y | Testis (Tes) | Fibrohistiocytosis | Tumor |
| 1 | B4 | Human | M | 70 y | Testis (Tes) | Normal | Benign non-neoplastic |
| 1 | B5 | Human | M | 47 y | Testis (Tes) | Tuberculosis | Diseased |
| 1 | B6 | Human | M | 30 y | Testis (Tes) | Tuberculosis | Diseased |
| 1 | B7 | Human | M | 58 y | Penis, Epididymis (Pen) | Adenoma | Tumor |
| 1 | B8 | Human | M | 63 y | Testis (Tes) | Seminoma | Tumor |
| 1 | C1 | Human | M | 29 y | Testis (Tes) | Seminoma | Tumor |
| 1 | C2 | Human | M | 29 y | Testis (Tes) | Seminoma | Tumor |
| 1 | C3 | Human | M | 44 y | Testis (Tes) | Seminoma | Tumor |
| 1 | C4 | Human | M | 70 y | Testis (Tes) | Seminoma | Tumor |
| 1 | C5 | Human | M | 36 y | Testis (Tes) | Seminoma | Tumor |
| 1 | C6 | Human | M | 25 y | Testis (Tes) | Seminoma | Tumor |
| 1 | C7 | Human | M | 30 y | Testis (Tes) | Seminoma | Tumor |
| 1 | C8 | Human | M | 28 y | Testis (Tes) | Seminoma | Tumor |
| 1 | D1 | Human | M | 29 y | Testis (Tes) | Seminoma | Tumor |
| 1 | D2 | Human | M | 29 y | Testis (Tes) | Seminoma | Tumor |
| 1 | D3 | Human | M | 44 y | Testis (Tes) | Seminoma | Tumor |
| 1 | D4 | Human | M | 70 y | Testis (Tes) | Seminoma | Tumor |
| 1 | D5 | Human | M | 36 y | Testis (Tes) | Seminoma | Tumor |
| 1 | D6 | Human | M | 25 y | Testis (Tes) | Seminoma | Tumor |
| 1 | D7 | Human | M | 30 y | Testis (Tes) | Seminoma | Tumor |
| 1 | D8 | Human | M | 28 y | Testis (Tes) | Seminoma | Tumor |
| 1 | E1 | Human | M | 34 y | Testis (Tes) | Seminoma | Tumor |
| 1 | E2 | Human | M | 32 y | Testis (Tes) | Seminoma | Tumor |
| 1 | E3 | Human | M | 56 y | Testis (Tes) | Seminoma | Tumor |
| 1 | E4 | Human | M | 69 y | Testis (Tes) | Normal | Benign non-neoplastic |
| 1 | E5 | Human | M | 1.5 y | Testis (Tes) | Endodermal sinus tumor | Tumor |
| 1 | E6 | Human | M | 52 y | Testis (Tes) | Malignant fibrohistiocytosis | Malignant |
| 1 | E7 | Human | M | 40 y | Testis (Tes) | Embryonal carcinoma | Malignant |
| 1 | E8 | Human | M | 72 y | Testis (Tes) | Non-Hodgkin's lymphoma | Malignant |
| 1 | F1 | Human | M | 34 y | Testis (Tes) | Seminoma | Tumor |
| 1 | F2 | Human | M | 32 y | Testis (Tes) | Seminoma | Tumor |
| 1 | F3 | Human | M | 56 y | Testis (Tes) | Seminoma | Tumor |
| 1 | F4 | Human | M | 69 y | Testis (Tes) | Normal | Benign non-neoplastic |
| 1 | F5 | Human | M | 1.5 y | Testis (Tes) | Endodermal sinus tumor | Tumor |
| 1 | F6 | Human | M | 52 y | Testis (Tes) | Malignant fibrohistiocytosis | Malignant |
| 1 | F7 | Human | M | 40 y | Testis (Tes) | Embryonal carcinoma | Malignant |
| 1 | F8 | Human | M | 72 y | Testis (Tes) | Non-Hodgkin's lymphoma | Malignant |
Copyright © 2013 LifeSpan BioSciences, Inc. All Rights Reserved
